ARTICLE | Distillery Therapeutics
Promoting CX3CL1 expression to treat Alzheimer's
February 25, 2020 9:10 PM UTC
INDICATION: Alzheimer's disease (AD) ...
BCIQ Company Profiles
BCIQ Target Profiles
INDICATION: Alzheimer's disease (AD) ...
BCIQ Company Profiles
BCIQ Target Profiles
BCIQ Company Profiles
BCIQ Target Profiles